Search Results
Mar 25, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces Launch of MAVAN (Made In America VAlidator Network), the Company's Proprietary Staking Solution
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Mar 25, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces Launch of MAVAN (Made In America VAlidator Network), the Company's Proprietary Staking Solution
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Mar 25, 2026, 08:30 ET Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
release; (ii) Talphera's developmental product candidates may not be beneficial to patients or healthcare providers or be successfully commercialized; (iii) risks relating to Talphera's ability to obtain regulatory approvals for its developmental product candidates; (iv) risks related to the ability of Talphera
More news about: Talphera, Inc.
Mar 25, 2026, 08:30 ET AES Announces Extension of Consent Solicitation for its 2028 Notes and Expiration of Consent Solicitations for its 2030 Notes and 2031 Notes
the completion of the Transaction, including obtaining required stockholder and regulatory approvals, are not satisfied in a timely manner or at all; (iii) potential litigation relating to the Transaction, including resulting expense or delay, and the effects of any outcomes related thereto; (iv) the risk
More news about: The AES Corporation
Mar 25, 2026, 08:30 ET DPL LLC Announces Extension of Expiration Time for Previously Announced Consent Solicitation
the completion of the Transaction, including obtaining required stockholder and regulatory approvals, are not satisfied in a timely manner or at all; (iii) potential litigation relating to the Transaction, including resulting expense or delay, and the effects of any outcomes related thereto; (iv) the risk
More news about: DPL LLC
Mar 25, 2026, 08:30 ET IPALCO Enterprises, Inc. Announces Extension of Expiration Time for Previously Announced Consent Solicitations
the completion of the Transaction, including obtaining required stockholder and regulatory approvals, are not satisfied in a timely manner or at all; (iii) potential litigation relating to the Transaction, including resulting expense or delay, and the effects of any outcomes related thereto; (iv) the risk
More news about: IPALCO Enterprises
Mar 25, 2026, 08:17 ET Volition Announces Detection of Over 95% of Early-Stage Cancers
96% (26/27)III100% (2/2)
More news about: VolitionRx Limited
Mar 25, 2026, 08:07 ET YY Group Holding Announces Estimated Total Assets and Net Assets per Share of $8.03 and $3.18, Respectively, for Fiscal Year 2025
forward-looking statement. These factors include, but are not limited to, (i) growth of the hospitality market (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business
More news about: YY Group Holding Limited
Mar 25, 2026, 08:00 ET VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatmentFully biological transplant eliminates
More news about: VERIGRAFT
Mar 25, 2026, 08:00 ET Lowe's Rolls Out Spring Savings and Free Same-Day Delivery on Mulch
Bulk, Member Volume Discount ("MVD"), Special Value, New Lower Price, Was: Now, Military Discount, Employee Discount, and Lowest Price Guarantee); (iii) associate discretion price adjustments; (iv) any services (such as but not limited to, rentals; extended protection/replacement plans; shipping, delivery,
More news about: Lowe's Companies, Inc.
Mar 25, 2026, 07:51 ET Einride Publishes Voluntary Safety Self-Assessment for Autonomous Heavy-Duty Trucks
[email protected] Merger Corp. IIIEric RosenfeldChief SPAC OfficerLegato Merger Corp. III[email protected] This
More news about: Einride
Mar 25, 2026, 06:45 ET IGT Shapes the Future of Gaming for Tribal Casino Operators at the 2026 Indian Gaming Tradeshow & Convention
April 1-2. As the premier annual tribal gaming event, IGA provides IGT with the ideal opportunity to showcase its momentum in driving Class II and Class III innovation via new games, cabinets and groundbreaking mobile technologies from Everi, an IGT brand.
More news about: IGT
Mar 25, 2026, 06:22 ET WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing.WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component
More news about: WuXi Biologics
Mar 25, 2026, 06:00 ET Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and Declares a Cash Dividend
increase of RMB205.3 million in costs of referral and service fees and (ii) an increase of RMB14.1 million in the costs for SMS, partially offset by (iii) a decrease of RMB15.2 million in personnel costs.Sales and marketing expenses increased by 178.4% year-over-year to RMB506.8
More news about: Waterdrop Inc.
Mar 25, 2026, 05:40 ET EOSE INVESTOR ALERT: Eos Energy Enterprises, Inc. Investors with Substantial Losses Have Opportunity to Lead tInvestor Class Action Lawsuit
set guidance; (ii) Eos Energy's battery line downtime was running well above industry norms, the design intent of the line, and internal forecasts; (iii) Eos Energy was experiencing delays in the ability for its automated bipolar production to hit quality targets; and (iv) Eos Energy's inadequate systems
More news about: Robbins Geller Rudman & Dowd LLP
Mar 25, 2026, 05:00 ET Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD
multimedia:https://www.prnewswire.com/news-releases/complement-therapeutics-announces-first-patient-dosed-with-ctx001-in-the-phase-iii-opti-gain-study-for-geographic-atrophy-secondary-to-amd-302723327.htmlSOURCE
More news about: Complement
Mar 25, 2026, 05:00 ET DouYu International Holdings Limited Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
adjusted the impact of (i) share of (income) loss in equity method investments, (ii) impairment losses and fair value adjustments on investments, and (iii) Impairment losses of intangible assets to understand and evaluate the Company's core operating performance. The non-GAAP financial measures are presented
More news about: DouYu International Holdings Limited
Mar 24, 2026, 22:34 ET From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson's Disease
targets.Galaxy Brain Scientific is already moving to bring these insights to the clinical frontline, having begun a pivotal registration trial for Class III devices dedicated to treating PD. "Our goal is to redefine the treatment paradigm for brain disorders," added Prof. Liu. "By moving from 'one-size-fits-all'
More news about: Galaxy Brain Scientific Inc.
Mar 24, 2026, 20:08 ET Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis
patient has been dosed in the Phase III clinical trial of HMI-115, its first-in-class monoclonal antibody with global rights, for the treatment of endometriosis. The dosing took place at the leading study site in China, Peking Union Medical College Hospital. This Phase III trial is a multicenter, randomized,
More news about: Hope Medicine Inc.
Mar 24, 2026, 17:15 ET ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc.
ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel's regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical
More news about: Robbins LLP
Mar 24, 2026, 16:45 ET NOAH HOLDINGS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER 2025 AND UNAUDITED FINANCIAL RESULTS FOR FULL YEAR 2025
primarily consisted of (i) compensation and benefits of RMB293.6 million (US$42.0 million); (ii) selling expenses of RMB60.8 million (US$8.7 million); (iii) general and administrative expenses of RMB98.1 million (US$14.0 million); (iv) provision for credit losses of RMB3.5 million (US$0.5 million); (v) other
More news about: Noah Holdings Limited
Mar 24, 2026, 16:12 ET INVESTOR DEADLINE: Gartner, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
generating "more certainty" in the demographics, which allegedly would result in the opportunity for continued CV growth for Gartner; and (iii) while tariff impacts continued to ease and settle and companies were acting with more certainty, Gartner's non-federal CV growth would fall even further
More news about: Robbins Geller Rudman & Dowd LLP
Mar 24, 2026, 16:10 ET YY Group (NASDAQ: YYGH) Appoints Arros AI Co-Founder Kai Yang as Chief AI Scientist to Accelerate AI-Powered Workforce Platform Development
forward-looking statement. These factors include, but are not limited to, (i) growth of the hospitality market (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business
More news about: YY Group Holding Limited
Mar 24, 2026, 16:05 ET AAR reports third quarter fiscal year 2026 results
including: (i) factors that adversely affect the commercial aviation industry; (ii) adverse events and negative publicity in the aviation industry; (iii) a reduction in sales to the U.S. government and its contractors; (iv) cost overruns and losses on fixed-price contracts; (v) nonperformance by subcontractors
More news about: AAR CORP.
Mar 24, 2026, 16:02 ET INVESTOR NOTICE: Camping World Holdings, Inc. (CWH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
optimize profit using "data analytics"; (ii) Camping World overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, Camping World would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; and (iv)
More news about: Robbins Geller Rudman & Dowd LLP